Page 16 - LabMedya - ENG - 07
P. 16

/labmedya


        16                                                                                HEALTH AND LABORATORY MAGAZINE






          OMEGA-3

          SUPPLEMENTATION

          COULD BOOST


          IMMUNOTHERAPY’S

          CANCER-FIGHTING

          POWER




           Immunotherapy and anti-
           inflammatory therapy were
           more effective when mice
           consumed omega-3s.











        Findings from a new study   Sources of omega-3s   models of primary and    experienced accelerated   mechanism of action of the
        performed in mice suggest   include fish, nuts, and seeds   metastatic tumors for the   tumor growth in certain   potentially synergistic an-
        that omega-3 fatty acids   while omegas-6s are found   new study. They began by   tumor types.      ti-tumor activity imparted
        could help immunothera-  in meats, eggs, and other   feeding the mice either a                      by omega-3 supplementa-
        py and other treatments   foods.                  standard diet or a diet high   In mice receiving the high   tion. They are conducting
        do a better job at fighting                       in omega-3 or 6 for 10 days   omega-3 diet and both   these studies with human
        cancer. Immunotherapies,   Omega-3 supplementation   prior to tumor injection   cancer treatments, up to   cancer tissues and cells,
        which stimulate the body’s   improves the efficacy of   and for the duration of the   67 percent of tumor growth   human immune cells, and
        own immune system to     immunotherapy in sub-    studies. One week after the   was inhibited compared to   animal models to aid
        attack cancer, have revolu-  cutaneous murine MB49   tumors were injected, mice   mice receiving no treat-  with translation to cancer
        tionized cancer treatment,   bladder cancer tumors.   in each diet group were   ment and a normal diet.   patients. These new results
        but they don’t work for   Credit: Abigail Kelly, Beth   started on immunotherapy,   This indicates possible   from Kelly and colleagues
        every patient.           Israel Deaconess Medical   anti-inflammatory therapy,   synergistic anti-tumor   may represent a new
                                 Center/Harvard Medical   both therapies together, or   activity, meaning that the   treatment approach that
        “Dietary interventions can   School               no treatment.            combined effect may be   remains to be evaluated in
        be powerful tools because                                                  greater than the sum of its   humans.
        they are relatively simple   In the new studies, Kelly   Omega-3 supplementation   parts.
        and inexpensive to imple-  and senior author Dipak   in combination with inhibi-
        ment,” said Abigail Kelly, a   Panigraphy wanted to   tion of sEH improves the   “We demonstrated, for the
        research assistant at Har-  find out how diets supple-  efficacy of immunotherapy   first time, that the combi-
        vard Medical School’s Beth   mented with these fatty   in subcutaneous murine   nation of immunotherapy
        Israel Deaconess Medical   acids affected the anti-tu-  Lewis Lung Carcinoma   and anti-inflammatory
        Center in Boston. “Our   mor activity of immune   tumors. Credit: Abigail Kel-  treatment (sEHi) was more
        findings show that ome-  checkpoint blockade      ly, Beth Israel Deaconess   effective when mice were
        ga-3 supplementation has   immunotherapy and an   Medical Center/Harvard   fed diets enriched with
        the potential to broadly im-  anti-inflammatory therapy   Medical School   omega-3 fatty acids,”
        prove immunotherapy and   that inhibits the enzyme                         said Kelly. “This is very
        other anti-cancer drugs in   soluble epoxide hydrolase   The researchers found   promising because dietary
        the clinical setting.”   (sEH). The immunotherapy   that dietary omega-3   supplementation is easy
                                 has regulatory approval   fatty acid supplementation   to implement for cancer
        Research from various lab-  and is being used clinically   blocked tumor growth in   patients and can be added
        oratories has suggested   while the anti-inflamma-  mice treated with immu-  for patients already on
        that omega-3 fatty acids   tory therapy is undergoing   notherapy, sEH inhibitor,   immunotherapy.”
        can help reduce cancer   clinical development.    or both treatments used
        risk whereas consuming                            together. In contrast, mice   The researchers are now
        too much omega-6 fatty   The researchers used     on the high-omega-6 diet   performing additional
        acids can stimulate cancer.   state-of-the-art mouse   and given immunotherapy   studies to determine the
   11   12   13   14   15   16   17   18   19   20